Arihant Oncology Private Limited
About Arihant Oncology Private Limited
Data last updated:
Arihant Oncology Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 15 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85190MH2021PTC367580.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khamavanti Chunilal Visharia (Managing Director) and Chunilal Ramji Visharia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B602 Skyline Villa B Wing 6th Floor, Near Hiranandani Hospital Powai Mumbai, Maharashtra, India – 400076.
As per the financials filed for FY 2025, the company reported a revenue of ₹65.83 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹9.37 Lakh (net margin 14.2%) and EBITDA of ₹9.39 Lakh (EBITDA margin 14.3%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
Company details
Contact details
Arihant Oncology Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB602 Skyline Villa B Wing 6th Floor, Near Hiranandani Hospital Powai Mumbai, Maharashtra, India – 400076
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Arihant Oncology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arihant Oncology is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Arihant Oncology Private Limited, buy the company report.
Financials of Arihant Oncology Private Limited
FY 2025 filings availableArihant Oncology Private Limited reported revenue of ₹65.83 Lakh (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 35% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹9.39 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹9.37 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 14.3% | |||
| Net Profit Margin | 14.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Arihant Oncology Private Limited, buy the company report.
Board of directors of Arihant Oncology Private Limited
Arihant Oncology has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chunilal Ramji Visharia | Director | 15 Sep 2021 | 5 Years 1 Months | Current |
| Khamavanti Chunilal Visharia | Managing Director | 15 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Arihant Oncology Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Elite Ayurveda Services Private Limited | ₹66.14 Lakh (FY 2024) | 8.0% | Bangalore, Karnataka, India | |||
| Sigma Diagnostics Limited | ₹66.12 Lakh (FY 2020) | -43.0% | Ludhiana, Punjab, India | |||
| Arihant Oncology Private Limitedthis company | ₹65.83 Lakh (FY 2025) | ₹9.37 Lakh | 14.2% | -35.0% | Mumbai, Maharashtra, India | |
| Manovikas Healthcare Services Private Limited | ₹65.76 Lakh (FY 2019) | 4.0% | Hyderavad, Telangana, India | |||
| Anam Cara Research Private Limited | ₹65.73 Lakh (FY 2025) | 240.0% | Guwahati, Assam, India | |||
| Health and Hopes Medical Assistance Private Limited | ₹65.43 Lakh (FY 2023) | -34.0% | New Delhi, Delhi, India |
To see the full peer comparison of Arihant Oncology Private Limited, buy the company report.
Auditor
Arihant Oncology Private Limited is audited by BRIJESH GADHIA AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BRIJESH GADHIA AND COMPANY | FY 2023 | 163883 |
Shareholding
The shareholding of Arihant Oncology Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Arihant Oncology Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arihant Oncology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arihant Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Arihant Oncology Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
No GST registration is on our record for Arihant Oncology Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Arihant Oncology Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Chunilal Ramji Visharia was appointed as Director on 15 Sep 2021.
Frequently asked questions
Arihant Oncology is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 15 September 2021 (5+ years old) and is registered under CIN U85190MH2021PTC367580.
Arihant Oncology has 2 current directors:
- Khamavanti Chunilal Visharia - Managing Director
- Chunilal Ramji Visharia - Director
The latest financial statements of Arihant Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Arihant Oncology is U85190MH2021PTC367580. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arihant Oncology was incorporated on 15 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Arihant Oncology by revenue are Elite Ayurveda Services Private Limited, Sigma Diagnostics Limited, Manovikas Healthcare Services Private Limited, Anam Cara Research Private Limited, Health and Hopes Medical Assistance Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities).
Chunilal Ramji Visharia was appointed as Director on 15 Sep 2021. Khamavanti Chunilal Visharia was appointed as Managing Director on 15 Sep 2021.
The registered office of Arihant Oncology is at B602 Skyline Villa B Wing 6th Floor, Near Hiranandani Hospital Powai Mumbai, Maharashtra, India – 400076.
Arihant Oncology operates in the healthcare industry, in the preventive health services segment.
Arihant Oncology can be reached at its registered office: B602 Skyline Villa B Wing 6th Floor, Near Hiranandani Hospital Powai Mumbai, Maharashtra, India – 400076.
Arihant Oncology is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
